SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
---------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported) SEPTEMBER 24, 1996
------------------
SPARTA PHARMACEUTICALS, INC.
- ------------------------------------------------------------------
(EXACT NAME OF REGISTRANT AS SPECIFIED IN CHARTER)
DELAWARE 0-23076 56-1755527
(STATE OR OTHER JURISDICTION (COMMISSION (IRS EMPLOYER
OF INCORPORATION) FILE NUMBER) IDENTIFICATION NO.)
111 ROCK RD. HORSHAM, PA 19044
- -----------------------------------------------------------------
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE)
Registrant's telephone number, including area code (215) 442-1700
--------------
<PAGE>
ITEM 1. CHANGES IN CONTROL OF REGISTRANT.
Not applicable.
ITEM 2. ACQUISITION OR DISPOSITION OF ASSETS.
Not applicable.
ITEM 3. BANKRUPTCY OR RECEIVERSHIP.
Not applicable.
ITEM 4. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT.
Not applicable.
ITEM 5. OTHER EVENTS
On September 24, 1996, Sparta Pharmaceuticals, Inc. issued a press
release filed as Exhibit 99.9 hereto announcing the appointment Dr.
Colin Bier to its Board of Directors.
ITEM 6. RESIGNATIONS OF REGISTRANT'S DIRECTORS.
Not applicable.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(a) Financial Statements of Sparta Pharmaceuticals, Inc.
-----------------------------------------------------
Not applicable.
(b) Pro Forma Financial Information
-------------------------------
Not applicable
(c) Exhibits
--------
99.9 -- Press Release, dated as of September 24, 1996, announcing
the appointment of Dr. Colin Bier to Sparta's Board of
Directors.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this amendment to be signed on its behalf by the
undersigned thereunto duly authorized.
SPARTA PHARMACEUTICALS, INC.
September 25, 1996 By: /s/ Jerry B. Hook
- ------------------ ------------------------
Date Jerry B. Hook, Ph.D. President,
Chief Executive Officer &
Director
(principal executive officer)
<PAGE>
EXHIBIT INDEX
- -------------------------------------------------------------------------------
EXHIBIT
NUMBER DESCRIPTION PAGE
- ------ ------------ ----
99.9 -- Press Release, dated as of September 24, 1996, 5
announcing the appointment of Dr. Colin Bier to
Sparta's Board of Directors.
CONTACTS: JERRY B. HOOK, PH.D. RONALD H. SPAIR
PRESIDENT & CEO VICE PRESIDENT & CFO
SPARTA PHARMACEUTICALS, INC. SPARTA PHARMACEUTICALS, INC.
215/442-1700, EXT. 205 215/442-1700, EXT. 207
FOR IMMEDIATE RELEASE
SPARTA PHARMACEUTICALS, INC. ANNOUNCES THE APPOINTMENT OF DR. COLIN BIER TO
----------------------------------------------------------------------------
THE BOARD OF DIRECTORS
----------------------
HORSHAM, PA, SEPTEMBER 24, 1996 -- SPARTA PHARMACEUTICALS, INC.
(NASDAQ:SPTA, SPTAU, SPTAW AND SPTAZ) announced today the appointment of Dr.
Colin Bier to Sparta's Board of Directors.
Dr. Bier is Managing Director of ABA BioResearch, an independent
bioregulatory consulting firm. He is a leading authority on toxicology,
pharmaceutical and biotechnology regulatory and strategic development. Dr. Bier
has extensive management experience in the biomedical sector having consulted,
managed and been affiliated with numerous important biotechnology enterprises,
and he serves as a director of several private companies and the following
publicly traded pharmaceutical biotechnology companies: NYMOX Corporation,
Boston Life Sciences, Maxim Pharmaceuticals and IAF Biochem Pharma. He received
a B.A. from Sir George Williams University (Montreal), an M.Sc. in Physiology
and Immunology from Long Island University and a Ph.D. in Pathology and
Toxicology from Colorado State University.
Sparta Pharmaceuticals, Inc. is a development stage
pharmaceutical company engaged in the business of acquiring the rights to, and
developing for commercialization, technologies and drugs for the treatment of
life threatening diseases, including cancer, cardiovascular disorders and acute
inflammatory diseases.
